Gene transfer therapy for neurodegenerative disorders.

Gene transfer therapy for neurodegenerative disorders. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Gene transfer therapy for neurodegenerative disorders. Abstract Text:

Andrew Feigin,David Eidelberg,

Recent advances in gene transfer technology have led to promising new therapies for neurodegenerative disorders. This article will review methods of gene transfer therapy and applications of these techniques to both genetic and sporadic neurodegenerative illnesses. The article will focus on Parkinson's disease, Huntington's disease, and Alzheimer's disease. Several promising gene therapy approaches to these diseases are being pursued both in animal models and in early human trials. Initial safety-tolerability results from these trials appear promising. It is therefore likely that the number of human trials of gene therapy for neurodegenerative disorders will increase over the coming years. (c) 2007 Movement Disorder Society.

Gene transfer therapy for neurodegenerative disorders. Publishing Authors By Initials

A Feigin,D Eidelberg,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Gene transfer therapy for neurodegenerative disorders. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Movement disorders : official journal of the Movem

VOLUME: 22

Page Numbers: 1223-8

Journal Abbreviation: Mov. Disord.

ISSN: 0885-3185

DAY: 15

MONTH: Jul

YEAR: 2007

Gene transfer therapy for neurodegenerative disorders. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8610688

Gene transfer therapy for neurodegenerative disorders. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Gene transfer therapy for neurodegenerative disorders. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Gene transfer therapy for neurodegenerative disorders.

AFFILIATION: Center for Neurosciences, The Feinstein Institute for Medical Research, North Shore-Long Island Jewish Health System, Manhasset, New York, USA.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Mov Disord

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Gene transfer therapy for neurodegenerative disorders Related Publications

• Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility.
• Abnormal metabolic networks in atypical parkinsonism.
• An examination of executive dysfunction associated with frontostriatal circuitry in Parkinson's disease.
• Callosal and non-callosal connexions between the sensory-motor cortices in cat and monkey.
• Cerebral glucose metabolism and D(2)/D (3) receptor availability in young adults with cannabis dependence measured with positron emission tomography.
• Changes in network activity with the progression of Parkinson's disease.
• Correlates of movement initiation and velocity in Parkinson's disease: A longitudinal PET study.
• Development of electrical activity in the cerebral cortex of the newborn rat.
• Dissociation of metabolic and neurovascular responses to levodopa in the treatment of Parkinson's disease.
• Dopaminergic suppression of brain deactivation responses during sequence learning.
• Functional imaging of cerebral blood flow and glucose metabolism in Parkinson's disease and Huntington's disease.
• Functional imaging of sequence learning in Parkinson's disease.
• Gene transfer therapy for neurodegenerative disorders.
• Habituation of somatosensory evoked potentials in the lemniscal system of the cat.
• Implicit and explicit aspects of sequence learning in pre-symptomatic Huntington's disease.
• Increased cerebellar activation during sequence learning in DYT1 carriers: an equiperformance study.
• Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease.
• Metabolic brain networks associated with cognitive function in Parkinson's disease.
• Metabolic correlates of subthalamic nucleus activity in Parkinson's disease.
• Microstructural white matter changes in primary torsion dystonia.
• Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease.
• Relationship between self-reported apathy and executive dysfunction in nondemented patients with Parkinson disease.
• Spectrum analysis of residual EEG changes following post-natal x-irradiation in rats.
• Subthalamic glutamic acid decarboxylase gene therapy: changes in motor function and cortical metabolism.
• Thalamic metabolism and symptom onset in preclinical Huntington's disease.
• The assessment of neurological systems with functional imaging.
• Thermoelectric freezing stage for serial brain sectioning.
• [Not Available.]
• [Not Available.]
• [Treatment of pain in neoplastic diseases.]